Sigyn Therapeutics Inc
(SIGY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,698 | -2,120 | -669 | -3,340 | -2,817 |
| Depreciation Amortization | 142 | 71 | 29 | 469 | 428 |
| Accounts payable and accrued liabilities | 165 | 122 | 64 | 147 | 150 |
| Other Working Capital | 608 | 469 | 201 | 1,264 | 1,115 |
| Other Operating Activity | 1,138 | 1,012 | 81 | 587 | 542 |
| Operating Cash Flow | $-646 | $-447 | $-294 | $-872 | $-582 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 720 | 435 | 295 | 953 | 772 |
| Other Financing Activity | 0 | 0 | 0 | -80 | -37 |
| Financing Cash Flow | $720 | $435 | $295 | $873 | $735 |
| Beginning Cash Position | 12 | 12 | 12 | 12 | 12 |
| End Cash Position | 86 | 1 | 13 | 12 | 165 |
| Net Cash Flow | $73 | $-12 | $1 | $1 | $153 |
| Free Cash Flow | |||||
| Operating Cash Flow | -646 | -447 | -294 | -872 | -582 |
| Free Cash Flow | -646 | -447 | -294 | -872 | -582 |